PBYI FY 2017 Earnings — Puma Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

PBYIPuma Biotechnology, Inc.

$299M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$28M

Gross Profit

$22M79.8% margin

Operating Income

-$292M-1055.6% margin

Net Income

-$292M-1054.2% margin

EPS (Diluted)

$-7.86

Cash Flow

Operating Cash Flow

-$173M

Free Cash Flow

-$223M

Stock-Based Comp.

$109M

Balance Sheet

Total Assets

$166M

Total Liabilities

$112M

Stockholders' Equity

$53M

Cash & Equivalents

$82M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$0	—
Gross Profit	$22M	-$1M	+2023.4%
Operating Income	-$292M	-$277M	-5.7%
Net Income	-$292M	-$276M	-5.8%